Series A · Healthtech · Prague, Czechia · Founded 2019 · 40–45 employees
Vitadio develops prescription digital therapeutics for type 2 diabetes and prediabetes, combining AI-driven lifestyle interventions with human health coach support. The company has achieved significant clinical validation, with patients using Vitadio reaching target blood sugar levels 4.1 times more often than standard care. They're the first digital health app for type 2 diabetes to obtain permanent DiGA status in Germany with full health insurance coverage. The startup raised €3 million in 2023 led by Theras Group and operates across Germany, Czech Republic, and Italy with plans for further European expansion.
No open roles listed right now.